Contact details
For medical information
Tel: +359 80 018 205
Email: safety-bg@gsk.com
To report an adverse event
Tel: +359 80 018 205
Email: safety-bg@gsk.com
For questions on our Ellipta and Nucala portfolio
Please contact Berlin-Chemie/A. Menarini Bulgaria EOOD
Tel: +359 2 454 0950
Email: bcsofia@berlin-chemie.com
For questions on supply and distribution of all other GSK medicines and vaccines
Please contact Phoenix Group
Tel: +359 29 658 123
For government and media enquiries
Please contact: WW.CEEurope-media@gsk.com
For any other enquires
Tel: +359 80 018 205
EFPIA disclosure
GSK fully supports the European Federation of Pharmaceutical Industries and Associations (EFPIA) Code on the disclosure of individual transfer of value from pharmaceutical companies to healthcare professionals and healthcare organisations.
We believe that it helps to create a better understanding about how the pharmaceutical industry partners and collaborates with HCPs and HCOs, and so increase confidence in the way that industry and the healthcare professions work together.
We publish disclosure reports in line with the EFPIA Code on the disclosure of individual transfers of value from pharmaceutical companies to healthcare professionals and healthcare organisations.
View our disclosure report for Bulgaria